Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 10 studies | 32% ± 10% | |
oligodendrocyte precursor cell | 6 studies | 31% ± 11% | |
endothelial cell | 5 studies | 21% ± 3% | |
glutamatergic neuron | 4 studies | 44% ± 18% | |
hepatocyte | 3 studies | 23% ± 5% | |
GABAergic neuron | 3 studies | 46% ± 5% | |
interneuron | 3 studies | 44% ± 17% | |
astrocyte | 3 studies | 22% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 41% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1795.55 | 2641 / 2642 | 100% | 46.26 | 705 / 705 |
kidney | 100% | 981.57 | 89 / 89 | 99% | 30.59 | 894 / 901 |
adrenal gland | 100% | 1449.06 | 258 / 258 | 98% | 17.43 | 225 / 230 |
intestine | 100% | 1353.19 | 966 / 966 | 98% | 12.97 | 515 / 527 |
skin | 98% | 1523.73 | 1775 / 1809 | 98% | 23.73 | 461 / 472 |
stomach | 96% | 661.74 | 344 / 359 | 98% | 12.95 | 279 / 286 |
thymus | 99% | 763.65 | 647 / 653 | 94% | 10.32 | 567 / 605 |
liver | 100% | 2305.92 | 226 / 226 | 92% | 23.39 | 374 / 406 |
esophagus | 98% | 679.75 | 1419 / 1445 | 91% | 9.67 | 167 / 183 |
bladder | 100% | 655.67 | 21 / 21 | 86% | 9.28 | 435 / 504 |
prostate | 94% | 547.23 | 231 / 245 | 90% | 7.18 | 454 / 502 |
lung | 93% | 693.50 | 539 / 578 | 88% | 8.13 | 1020 / 1155 |
breast | 99% | 1044.12 | 456 / 459 | 79% | 6.65 | 878 / 1118 |
uterus | 99% | 689.45 | 169 / 170 | 78% | 7.52 | 359 / 459 |
ovary | 93% | 427.73 | 167 / 180 | 61% | 4.07 | 262 / 430 |
pancreas | 17% | 51.66 | 56 / 328 | 88% | 8.17 | 157 / 178 |
spleen | 100% | 2482.24 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 1218.69 | 1202 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 9.89 | 26 / 29 |
tonsil | 0% | 0 | 0 / 0 | 89% | 9.11 | 40 / 45 |
blood vessel | 88% | 458.53 | 1177 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 9.99 | 69 / 80 |
heart | 80% | 373.77 | 693 / 861 | 0% | 0 | 0 / 0 |
muscle | 63% | 260.08 | 502 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 47% | 310.86 | 438 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0052651 | Biological process | monoacylglycerol catabolic process |
GO_2001311 | Biological process | lysobisphosphatidic acid metabolic process |
GO_0099178 | Biological process | regulation of retrograde trans-synaptic signaling by endocanabinoid |
GO_0046889 | Biological process | positive regulation of lipid biosynthetic process |
GO_0060292 | Biological process | long-term synaptic depression |
GO_0046464 | Biological process | acylglycerol catabolic process |
GO_2000124 | Biological process | regulation of endocannabinoid signaling pathway |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0019369 | Biological process | arachidonic acid metabolic process |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0009395 | Biological process | phospholipid catabolic process |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0032281 | Cellular component | AMPA glutamate receptor complex |
GO_0098982 | Cellular component | GABA-ergic synapse |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0004620 | Molecular function | phospholipase activity |
GO_0047372 | Molecular function | acylglycerol lipase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ABHD6 |
Protein name | Abhydrolase domain containing 6, acylglycerol lipase Monoacylglycerol lipase ABHD6 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 6) |
Synonyms | |
Description | FUNCTION: Lipase that preferentially hydrolysis medium-chain saturated monoacylglycerols including 2-arachidonoylglycerol . Through 2-arachidonoylglycerol degradation may regulate endocannabinoid signaling pathways (By similarity). Also has a lysophosphatidyl lipase activity with a preference for lysophosphatidylglycerol among other lysophospholipids (By similarity). Also able to degrade bis(monoacylglycero)phosphate (BMP) and constitutes the major enzyme for BMP catabolism . BMP, also known as lysobisphosphatidic acid, is enriched in late endosomes and lysosomes and plays a key role in the formation of intraluminal vesicles and in lipid sorting . . |
Accessions | ENST00000478253.6 C9J010 ENST00000295962.8 ENST00000463756.5 ENST00000485900.1 C9JNE7 Q9BV23 ENST00000475982.5 F8WBP4 |